Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial

Fig. 2

Hemodynamic variations in the ivabradine group (n = 14) between time of dobutamine initiation (LCOS), ivabradine initiation (H0), and cessation. Bold lines represent median values; dotted lines indicate quartiles 1 and 3. Abbreviations: bpm beats per minute, LCOS low cardiac output syndrome, LVUT last value under treatment

Back to article page